Quick Heal Technologies Limited has informed the Exchange regarding Board meeting held on August 07, 2025.
QUICKHEAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Quick Heal Technologies reported weak Q1 FY26 results with consolidated revenue falling 18.6% year-on-year to ₹57.2 crore, compared to ₹70.3 crore in Q1 FY25. The company swung to a loss with EBITDA of ₹(9.7) crore and PAT of ₹(5.5) crore, versus a profit of ₹2.6 crore and ₹4.0 crore respectively a year earlier. Both consumer and enterprise segments declined sharply, with consumer revenue dropping 27.8% and enterprise revenue down 2.3%. The board confirmed the resignation of CEO Vishal Salvi, who steps down effective August 31, 2025, after his exit was accepted on July 9. The board appointed Ms. Amita Mirajkar as an Additional Woman Independent Director and P G BHAGWAT LLP as Internal Auditor for FY 2025-26. The statutory auditors M/s MSKA & Associates issued an unmodified limited review report on the results.
Negative near-term sentiment likely due to steep revenue decline, return to losses, and CEO departure during a challenging quarter. Shareholders should watch for new CEO appointment, revival in consumer business, and enterprise deal closures in coming quarters. The independent director addition and strong promoter holding (72%) provide some governance stability.